Home › Drug Conjugates Lure Investment
 

Keywords :   


Drug Conjugates Lure Investment

2013-10-21 10:15:43| Biotech - Topix.net

Only two antibody-drug conjugates are on the market- Roche's Kadcyla for breast cancer and Seattle Genetics 's Adcetris for lymphoma-but developers are stepping up investment in this new drug class.

Tags: investment drug lure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10House prices close to record high, says Halifax
07.10Hurricane Milton Public Advisory Number 7A
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Atlantic Tropical Weather Outlook
07.10Eastern North Pacific Tropical Weather Outlook
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Graphics
More »